Mastercard is fighting off attempts to include about 14 million dead people as claimants to a $19.3 billion British class action on alleged overcharging that occurred between May 1992 and June 2008.
Lawyer Mark Hoskins, who is representing the global payment processor, told London’s Competition Appeal Tribunal (CAT) that a claim cannot be brought in the name of a deceased person. He added that an application to add customers who died between 1992 and 2008 in the suit was a “nullity”.
Former financial ombudsman Walter Merricks, who is leading the claim, alleges Mastercard charged retailers excessive “interchange” fees and that those fees were passed on to consumers as retailers raised prices.
Mastercard supposedly overcharged around 60 million people in Great Britain, including about 14 million who have since died, over the period.
The case could entitle adults and their estates to roughly 300 pounds each if successful.
Hoskins said attempts to add new parties, or their administrators, personal representatives, executors, or next of kin was also time-barred. The company is also resisting attempts to add compound interest to the claim.
The case was brought to the CAT in 2016 but was blocked by the tribunal in 2017.
However, the UK Supreme Court in December allowed the action to proceed.
Mastercard says it “fundamentally" disagrees with the claim, noting that people benefitted from its payments technology and that the lawsuit is driven by US lawyers and backed by money-making organizations.


Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
OpenAI Tightens AI Safety Monitoring After Security Incidents
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
REPAY Stock Rises After Visa Platform Connect Collaboration
Standard Chartered Expands Hedge Fund Access for Wealth Clients 



